December 23, 2025
According to market projections, the oncology NGS sector is expected to grow from USD 508.95 million in 2024 to USD 2,193.49 million by 2034, reflecting a CAGR of 15.73%. The demand for NGS in oncology is high due to growing cases of cancer and R&...
November 01, 2025
According to market projections, the oncology drugs sector is expected to grow from USD 204.39 billion in 2024 to USD 360.79 billion by 2034, reflecting a CAGR of 6.29%. The oncology drugs market is growing due to the increasing incidence of cancer, ...
November 01, 2025
According to market projections, the global oncology API market, valued at USD 41.79 billion in 2024, is anticipated to reach USD 69.55 billion by 2034, growing at a CAGR of 5.24% over the next decade. The rising prevalence of cancer and the growing ...
October 16, 2025
The oncology biomarker market is valued at USD 38.62 billion in 2025 and is projected to reach USD 113.54 billion by 2034, growing at a CAGR of 12.73%. The report covers market segments by biomarker type, including genomic (35% share in 2024) and pro...
October 16, 2025
According to market projections, the oncology devices sector is expected to grow from USD 150.35 billion in 2024 to USD 776.3 billion by 2034, reflecting a CAGR of 17.84%. The increasing prevalence and awareness of cancer and the shift towards person...
November 01, 2025
According to market projections, the oncology drug discovery sector is growing due to the rising prevalence of cancer and increasing demand for targeted, personalized therapies. Advances in genomics and biotechnology are accelerating the development ...
October 15, 2025
Market insights predict, the oncology automation industry is expected to grow from USD 2.82 billion in 2024 to USD 7.77 billion by 2034, driven by a CAGR of 10.68%. The oncology automation market is growing due to rising cases of cancer, leading to a...
November 01, 2025
According to market projections, the oncology clinical trial sector is expected to grow from USD 13.64 billion in 2024 to USD 22.85 billion by 2034, reflecting a CAGR of 5.30%. Growing patient awareness, better diagnostic tools have increased the dem...
November 28, 2025
Forecasts suggest that the oncology molecular diagnostics market will expand from USD 3.48 billion in 2025 to USD 10.93 billion by 2035, with a CAGR of 12.13% during this period. In 2024, North America led the global oncology molecular diagnostics ma...
November 01, 2025
According to forecasts, the global oncology companion diagnostic market will grow from USD 5.24 billion in 2024 to USD 12.07 billion by 2034, with an expected CAGR of 8.73%. Across the world, North America showed dominance due to its possession of a ...
November 20, 2025
Based on market forecasts, the global oncology market, projected at USD 225.05 billion in 2024, is expected to reach USD 600.97 billion by 2034, growing at a CAGR of 11.54% over the forecast period.The oncology market is expanding due to rising can...
November 01, 2025
Market insights predict, the oncology biosimilars industry is expected to grow from USD 6.7 billion in 2024 to USD 36.23 billion by 2034, driven by a CAGR of 18.47%. The oncology biosimilars market is witnessing rapid growth, offering similar and c...
October 16, 2025
Market insights predict, the AI in oncology industry is expected to grow from USD 1.95 billion in 2024 to USD 25.02 billion by 2034, driven by a CAGR of 29.36%. The AI in oncology market is growing due to this technology transforming cancer imaging, ...
November 14, 2025
Based on market forecasts, the DNA methylation sector will expand from USD 2.05 billion in 2025 to USD 7.36 billion by 2035, experiencing a CAGR of 13.64%. The emerging trend of genomic imprinting and gene expression regulation drives the importance ...
October 17, 2025
The global Pre-Dx oncology market is growing with rising cancer incidence and advanced early detection technologies. North America led with 45% share in 2024, while Asia Pacific is fastest-growing. Liquid biopsy tests accounted for 40% revenue, MCED ...
November 17, 2025
According to market projections, the radiation oncology sector is expected to grow from USD 12.45 billion in 2025 to USD 36.78 billion by 2035, reflecting a CAGR of 11.44%. The rising prevalence of cancer and technological advancements drive the glob...
November 24, 2025
Market insights predict the APAC clinical trials industry will increase from USD 18.87 billion in 2025 to USD 41.33 billion by 2035, achieving a CAGR of 7.16%. The market is growing due to the increasing demand for new and effective therapies and ris...
December 19, 2025
The precision oncology market size is calculated at $132.87 billion in 2025 is to hit $341.51 billion by 2035. COTA, Inc. and Guardant Health collaborated to advance biomarker-based cancer therapies. Caris Life Sciences added UVA Cancer Center to its...
October 22, 2025
Projections indicate that, GMP peptides industry is projected to rise from USD 1.3 billion in 2024 to USD 2.9 billion by 2034, reflecting a CAGR of 8.35% over the next decade. The growing demand for peptide drugs and technological advancements drives...
October 07, 2025
According to market projections, the Europe pharmaceutical market, valued at USD 467.59 billion in 2024, is anticipated to reach USD 820.05 billion by 2034, growing at a CAGR of 5.78% over the next decade. The Europe pharmaceutical market is expandin...
October 28, 2025
Based on market forecasts, the U.S. oncology sector will expand from USD 72.79 billion in 2024 to USD 211.78 billion by 2034, experiencing a CAGR of 11.75%. The West region led the market due to the vital contribution of California in the oncology ...
October 01, 2025
According to market projections, the peptide therapeutics sector is expected to grow from USD 49.17 billion in 2024 to USD 81.5 billion by 2034, reflecting a CAGR of 5.35%. The peptide therapeutics market is growing due to rising demand for personali...
November 01, 2025
Market insights predict, the brachytherapy industry is expected to grow from USD 1.04 billion in 2024 to USD 2.10 billion by 2034, driven by a CAGR of 7.27%. The market is growing due to the increasing prevalence and rising demand for targeted, minim...
November 01, 2025
Forecasts suggest that the non-oncology precision medicine market will expand from USD 83.87 billion in 2024 to USD 193.16 billion by 2034, with a CAGR of 8.7% during this period. Non-Oncology Precision Medicine tailors treatments to individual patie...
October 16, 2025
The veterinary oncology market reached USD 1.58 billion in 2024 and is set to grow to USD 1.77 billion in 2025, reaching USD 4.86 billion by 2034 at a CAGR of 12.14%. The report covers market segmentation by animal, therapy, and cancer type, regional...
December 23, 2025
Market insights predict, the targeted therapy industry is expected to grow from USD 80.18 billion in 2024 to USD 155.82 billion by 2034, driven by a CAGR of 6.87%. In 2024, North America led the targeted therapy market (32%), with Asia Pacific set fo...
November 01, 2025
Based on market forecasts, the U.S. oncology molecular diagnostics sector will expand from USD 810 million in 2024 to USD 2570.17 million by 2034, experiencing a CAGR of 12.24%. In 2024, breast cancer dominated the market, while liver cancer is expec...
October 28, 2025
The advanced liver cancer treatment drugs market is expanding due to increased adoption of systemic therapies over traditional chemotherapy and growing approvals of immuno-oncology agents. North America led the market due to the presence of a well-de...
November 01, 2025
Market insights predict the global clinical trial imaging industry will increase from USD 2.41 billion in 2024 to USD 5.58 billion by 2034, achieving a CAGR of 8.8%. The market is growing due to the increasing adoption of advanced imaging technologie...
December 22, 2025
Market insights predict the global hemato-oncology testing industry will increase from USD 3.56 billion in 2024 to USD 11.47 billion by 2034, achieving a CAGR of 12.4%. In 2023, service offerings led the market with a 58% share. Leukemia remained the...
December 24, 2025
Projections indicate that, surgical microscope industry is projected to rise from USD 1.37 billion in 2024 to USD 3.87 billion by 2034, reflecting a CAGR of 10.97% over the next decade.Investments in healthcare infrastructure, especially in emergin...
November 01, 2025
According to market projections, the U.S. oncology drugs sector is expected to grow from USD 95.69 billion in 2024 to USD 246.85 billion by 2034, reflecting a CAGR of 9.94%. The extensive research, scientific innovations, and the market penetration...
November 01, 2025
The multiple modalities in oncology market is expanding due to increasing tumor heterogeneity as well as growing treatment approaches. North America led the market due to the presence of the advanced healthcare sector....
November 01, 2025
The microfluidics in oncology market is growing due to this system offering more sensitive and precise detection of cancer biomarkers and therapeutic approaches than traditional assays....
November 01, 2025
The rising prevalence of cancer and technological advancements are the major growth factors of the market. North America dominated the global market, owing to favorable government initiatives and increasing investments....
November 01, 2025
Rising advantages of AI and ML in the world are reducing timelines, cost-effective approaches in drug discovery and clinical trials are driving the global market. North America was dominant in the market due to technological advancements by using AI ...
November 01, 2025
The rapid genomic diagnostics market is rising due to the growing focus on rare disease & genetic disease diagnostics. North America’s dominance is attributed to technological advancements in bioinformatics....
November 01, 2025
Based on market forecasts, the global tele-oncology market, projected at USD 4.74 billion in 2024, is expected to reach USD 20.48 billion by 2034, growing at a CAGR of 15.76% over the forecast period. A sure sign of the adoption of advanced he...
November 01, 2025
Market insights predict the global radionuclide drug conjugates (RDC) industry will increase from USD 3.24 billion in 2024 to USD 8.87 billion by 2034, achieving a CAGR of 10.54%. The global radionuclide drug conjugates (RDC) market is growing stro...
November 01, 2025
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market...
November 01, 2025
Based on market forecasts, the global radiotherapy market, projected at USD 7.88 billion in 2024, is expected to reach USD 15.63 billion by 2034, growing at a CAGR of 7.09% over the forecast period. The market is expanding due to the increasing glo...
November 01, 2025
The U.S. oncology pharmaceutical market is expanding due to increasing cancer awareness as well as growing cancer drug development. ...
November 01, 2025
Based on market forecasts, the global GCC compounding pharmacy market, projected at USD 16.39 million in 2024, is expected to reach USD 40.26 million by 2034, growing at a CAGR of 9.27% over the forecast period.The growing demand for personalized med...
November 01, 2025
Based on market forecasts, the global clinical trial services market, projected at USD 60.7 billion in 2024, is expected to reach USD 141.85 billion by 2034, growing at a CAGR of 8.85% over the forecast period. The clinical trial services market is...
November 01, 2025
Market insights predict, the humanized mouse and rat model industry is expected to grow from USD 257.2 million in 2024 to USD 563.03 million by 2034, driven by a CAGR of 8.15%. The humanized mouse and rat model market is increasing due to growing dem...
November 01, 2025
According to market projections, the immuno-oncology drugs sector is expected to grow from USD 94 billion in 2024 to USD 421.27 billion by 2034, reflecting a CAGR of 16.34%. Across the globe, a rising number of cancer patients is associated with the ...
November 01, 2025
According to market projections, the global biopharmaceutical contract manufacturing market, valued at USD 40.14 billion in 2024, is anticipated to reach USD 115.65 billion by 2034, growing at a CAGR of 11.14% over the next decade.The biopharmaceut...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com